Anesthetic Considerations in Patients with Valvular Heart Disease

 

Valve area (cm2)

Maximal aortic velocity (m/s)

Mean pressure gradient (mmHg)

Mild

>1.5

<3.0

<25

Moderate

1.0–1.5

3.0–4.0

25–40

Severe

0.6–0.9

>4.0

>40

Critical

<0.6

>4.0

>70





 







    1. 4.


      What are the different grades for mitral regurgitation? (Table 5.2) [1]


      Table 5.2
      Different grades for mitral regurgitation


























































       
      Mild

      Moderate

      Severe

      Angiographic grade

      1+

      2+

      3+–4+

      Color Doppler jet area

      Small, central jet <4 cm2 or <20% of left atrial size

      Signs of MR greater than mild, but not severe

      Vena contracta width >0.7 cm2 with large central jet (area >40% of left atrium) or with a wall-impinging jet swirling in left atrium

      Doppler Vena contracta width (cm)

      <0.3

      0.3 – 0.69

      ≥0.7

      Regurgitant volume (ml/beat)

      <30

      30-59

      ≥60

      Regurgitant fraction (%)

      <30

      30-49

      ≥50

      Regurgitant orifice area (cm2)

      <0.2

      0.2–0.39

      ≥0.4

      Left atrial size

      Normal, unless other causes of left atrial dilation

      Normal or dilated

      Dilated, except acute MR

      Left ventricular size

      Normal, unless other causes of left ventricular dilation

      Normal or dilated

      Dilated, except acute MR

      Mitral leaflets or support apparatus

      Normal or abnormal

      Normal of abnormal

      Abnormal/flail leaflet, ruptured papillary muscle

       




    1. 5.


      What is the natural progression of aortic stenosis?

       

    Aortic stenosis is the most common valvular lesion in the United States. Aortic stenosis is classically associated with a prolonged asymptomatic period followed by rapid development of symptoms. The three primary symptoms are angina, syncope and dyspnea on exertion (symptom of heart failure). Without intervention, these correlate with an average life expectancy of two to five years.

    Risk factors for developing aortic stenosis include: increased age, male gender, dyslipidemia, diabetes, hypertension, smoking, renal insufficiency, or abnormal valve substrate. In high-risk patients, persistent inflammation, shear stress and pro-calcific stimuli ultimately result in valvular obstruction, decreased left ventricular ejection fraction and onset of symptoms. [2].


    1. 6.


      What is the natural progression of mitral regurgitation

       

    Mitral regurgitation most commonly develops gradually because the left atrium and left ventricle are initially able to compensate for regurgitant flow. The left atrium accommodates the regurgitant volume by dilating, while the left ventricle undergoes remodeling and hypertrophy to maintain adequate forward flow. However, with an increasing regurgitant volume, the myocardial demand exceeds supply and results in decreased forward stroke volume, reduced cardiac output and subsequently decompensated heart failure.

    In instances of acute mitral regurgitation, there is an abrupt increase in left atrial pressure without any time for left atrial or ventricular compensation; thus, the patient often develops acute pulmonary edema, decompensated heart failure, and cardiogenic shock.


    1. 7.


      How does aortic stenosis change the physiology of the heart?

       

    The primary physiologic change in aortic stenosis is left ventricular outflow obstruction. Left ventricular outflow obstruction leads to an increased left ventricular systolic pressure and a prolonged ejection time in order to maintain cardiac output. To meet demand, the left ventricle undergoes concentric hypertrophy. With the reduction in LV compliance, the stroke volume becomes fixed. Myocardial oxygen demand increases in the presence of a hypertrophied left ventricle; however, coronary oxygen supply can be limited secondary due to the myocardial hypertrophy. The result is left ventricular dysfunction, myocardial ischemia and, without intervention, left ventricular failure.
    Oct 9, 2017 | Posted by in Uncategorized | Comments Off on Anesthetic Considerations in Patients with Valvular Heart Disease

    Full access? Get Clinical Tree

    Get Clinical Tree app for offline access